Westlake Village’s Ember LifeSciences raised $16.5M in Series A funding for its cold chain technology. Learn how they are ...

Cytisinicline likely the best therapy to quit smoking, could be first FDA-approved cessation drug in 20 years.

In a special report, Hyderabad Police Commissioner V.C. Sajjanar details the city's law and order strategy for the upcoming ...

President Trump has instructed Attorney General Pam Bondi to finalize a decision on marijuana rescheduling by the end of January, Anthony ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central ...

Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, ...

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

• CapsoVision, Inc. shares rose 13.5% to $10.09 amid routine trading activity. • The company reported a loss of $0.17 per share, exceeding analyst estimates of a $0.14 loss. • Trading volume reached ...